Sinopharm Group Co Ltd
SWB:X2S
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Sinopharm Group Co Ltd
SWB:X2S
|
CN |
|
Fugro NV
LSE:0LNT
|
NL |
|
R
|
Ralph Lauren Corp
XMUN:PRL
|
US |
|
D
|
Daikin Industries Ltd
XBER:DKI
|
JP |
|
B
|
Bio-Techne Corp
SWB:TE1
|
US |
|
B
|
Bank of Communications Co Ltd
XBER:C4C
|
CN |
|
C
|
Cardinal Health Inc
LSE:0HTG
|
US |
|
Life Healthcare Group Holdings Ltd
F:L53
|
ZA |
|
Silvercorp Metals Inc
TSX:SVM
|
CA |
|
M
|
Mitsubishi Electric Corp
XBER:MIE1
|
JP |
|
S
|
Swiss Re AG
LSE:0QL6
|
CH |
|
Mitsubishi Electric Corp
LSE:MEL
|
JP |
|
C
|
Cencora Inc
SWB:ABG
|
US |
|
Glencore PLC
LSE:GLEN
|
CH |
|
R
|
Ralph Lauren Corp
DUS:PRL
|
US |
|
H
|
H & R Block Inc
F:HRB
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
F
|
First Majestic Silver Corp
DUS:FMV
|
CA |
|
Qingdao Port International Co Ltd
OTC:QNDPF
|
CN |
|
AeroVironment Inc
LSE:0HAL
|
US |
|
Sohgo Security Services Co Ltd
OTC:SOHGF
|
JP |
|
L
|
Lloyds Banking Group PLC
SWB:LLD
|
UK |
|
Biomarin Pharmaceutical Inc
NASDAQ:BMRN
|
US |
|
F
|
Fujikura Ltd
XBER:FJK
|
JP |
Wall St Price Targets
X2S Price Targets Summary
Sinopharm Group Co Ltd
According to Wall Street analysts, the average 1-year price target for X2S is 2.5399 EUR with a low forecast of 1.8906 EUR and a high forecast of 3.1182 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is X2S's stock price target?
Price Target
2.5399
EUR
According to Wall Street analysts, the average 1-year price target for X2S is 2.5399 EUR with a low forecast of 1.8906 EUR and a high forecast of 3.1182 EUR.
What is the Revenue forecast for Sinopharm Group Co Ltd?
Projected CAGR
5%
Over the last 14 years, the compound annual growth rate for Revenue has been 13%. The projected CAGR for the next 3 years is 5%.
What is the Gross Profit forecast for Sinopharm Group Co Ltd?
Projected CAGR
9%
Over the last 14 years, the compound annual growth rate for Gross Profit has been 12%. The projected CAGR for the next 3 years is 9%.
What is the Operating Income forecast for Sinopharm Group Co Ltd?
Projected CAGR
26%
Over the last 14 years, the compound annual growth rate for Operating Income has been 11%. The projected CAGR for the next 3 years is 26%.
What is the Pre-Tax Income forecast for Sinopharm Group Co Ltd?
Projected CAGR
10%
Over the last 14 years, the compound annual growth rate for Pre-Tax Income has been 12%. The projected CAGR for the next 3 years is 10%.
What is the Net Income forecast for Sinopharm Group Co Ltd?
Projected CAGR
10%
Over the last 14 years, the compound annual growth rate for Net Income has been 11%. The projected CAGR for the next 3 years is 10%.
